Prime Capital Investment Advisors, LLC

Position in CRBU — Caribou Biosciences, Inc.

CIK 1731446 OVERLAND PARK, KS

Position in CRBU

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$61,398

+$7,443 QoQ

Shares Held

32,315

-4.8% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Prime Capital Investment Advisors, LLC holds $14,447,509 across 15 Biotechnology names. CRBU ranks #11 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	13,916	$10,752,058
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,334	$1,042,224
3	ARWR	Arrowhead Pharmaceuticals, Inc.	15,826	$992,290
4	VKTX	Viking Therapeutics, Inc.	11,343	$369,101
5	IONS	Ionis Pharmaceuticals Inc	3,971	$298,182
6	IMTX	Immatics N.V.	30,000	$295,200
7	MRNA	Moderna, Inc.	4,639	$235,661
8	IBRX	ImmunityBio, Inc.	18,870	$144,732

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$61,398	32,315	-4.8%	Shares	Sole	2026-05-08
2025-12-31	$53,955	33,934	-2.1%	Shares	Sole	2026-01-21
2025-09-30	$80,790	34,674	-8.7%	Shares	Sole	2025-11-05
2025-06-30	$47,871	37,993	-29.6%	Shares	Sole	2025-07-23
2025-03-31	$49,282	53,979	-3.2%	Shares	Sole	2025-05-13
2024-12-31	$88,661	55,762	+260.4%	Shares	Sole	2025-02-12
2024-09-30	$30,323	15,471	-3.4%	Shares	Sole	2024-11-05
2024-06-30	$26,269	16,018	-1.8%	Shares	Sole	2024-08-09
2024-03-31	$83,833	16,310	-7.7%	Shares	Sole	2024-05-15
2023-12-31	$101,283	17,676	-51.5%	Shares	Sole	2024-01-24
2023-09-30	$174,293	36,463	-9.6%	Shares	Sole	2023-11-09
2023-06-30	$171,347	40,317	+53.1%	Shares	Sole	2023-08-08
2023-03-31	$139,817	26,331	—	Shares	Sole	2023-05-05
No filing history on record for this holder in this stock.